stocksSUPRIYA
SUPRIYA

Supriya Lifescience Ltd.

828.70-21.9 (-2.57%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Supriya Lifescience Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Supriya Lifescience Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Enclosed herewith is the Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018, received from RTA.
  • General4 Jul 2026
    Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
    Enclosed herewith is the intimation for submission under Regulation 30 of SEBI (LODR) Regulations, 2015.
  • General23 Jun 2026
    Email Communication To Shareholders Regarding Dividend Taxation Provisions.
    Email Communication to Shareholders regarding Dividend Taxation Provisions.
  • Closure of Trading Window20 Jun 2026
    Closure of Trading Window
    Enclosed herewith is the intimation for trading window closure for declaration of Unaudited Financial Results for quarter ending on June 30, 2026.
  • Analyst / Investor Meet15 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Analyst / Investor Meeting is enclosed herewith.
  • Analyst / Investor Meet9 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Investor/Analyst call is enclosed.
  • Reg.24(A)-Annual Secretarial Compliance30 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Enclosed herewith is the Annual Secretarial Compliance Report
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording and Outcome of Earnings Call is enclosed herewith.
  • Newspaper Publication28 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Audited Financial Results is enclosed herewith.
  • Press Release / Media Release28 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Enclosed herewith is the Press Release.
  • Dividend27 May 2026
    Corporate Action-Board to consider Dividend
    Enclosed herewith announcement pertaining to Dividend declared by the Company at its Board Meeting
  • Outcome of Board Meeting27 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of the Board Meeting is enclosed herewith.
  • Analyst / Investor Meet23 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Results Earnings Call for the Audited Financial Results for quarter and year ended march 31, 2026 is enclosed herewith along with dial in details and link for joining the call. Kindly ....
  • Board Meeting20 May 2026
    Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2026 And Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial Year Ended March 31, 2026.
    Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve In terms of Regulation ....
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A30 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • General22 Apr 2026
    Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Update On Inspection By United States Food & Drug Administration (USFDA)
    Enclosed herewith Announcement pertaining to update on USFDA.
  • Postal Ballot11 Apr 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    The Scrutinizers Report and Voting Results for the Postal Ballot Conducted by the Company are enclosed herewith.
  • Postal Ballot11 Apr 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Voting Results and Scrutinizers Report for Postal Ballot conducted by the Company are enclosed herewith.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Enclosed herewith is the Certificate under Regulation 74 (5) of SEBI (Depository and Participants) Regulation, 2018 for the quarter ended March 31, 2026. Kindly take the same on record
  • Closure of Trading Window25 Mar 2026
    Closure of Trading Window
    Intimation for Closure of Trading Window for declaration of Audited Financial Results for quarter and year ending March 31, 2026 is enclosed herewith. Kindly take the same on record.

Frequently Asked Questions

Where can I download the annual report of Supriya Lifescience Ltd.?
Annual reports of Supriya Lifescience Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Supriya Lifescience Ltd.?
Quarterly earnings results and presentations of Supriya Lifescience Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Supriya Lifescience Ltd. publish earnings call transcripts?
Earnings call transcripts of Supriya Lifescience Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Supriya Lifescience Ltd.?
Investor presentations and annual day presentations of Supriya Lifescience Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Supriya Lifescience Ltd.?
Corporate announcements and regulatory filings of Supriya Lifescience Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Supriya Lifescience Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Supriya Lifescience Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Supriya Lifescience Ltd.?
The ISIN (International Securities Identification Number) of Supriya Lifescience Ltd. is INE07RO01027. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Supriya Lifescience Ltd. listed?
Supriya Lifescience Ltd. is listed on NSE and BSE. The NSE symbol is SUPRIYA and the BSE code is -.
Where can I find the shareholding pattern of Supriya Lifescience Ltd.?
The quarterly shareholding pattern of Supriya Lifescience Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Supriya Lifescience Ltd. on Sharpely?
Share price data for Supriya Lifescience Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.